User-centered Design of the eyeGuide: A Tailored Glaucoma Behavior Change Program.

Journal Article (Journal Article)

PURPOSE: We employed user-centered design to refine a prototype of the eyeGuide, a novel, tailored behavior change program intended to improve medication adherence among glaucoma patients. PATIENTS: Glaucoma patients age 40 years and above prescribed ≥1 glaucoma medication were included. METHODS: The eyeGuide consists of tailored educational content and tailored testimonials in which patients share how they were able to overcome barriers to improve their medication adherence. A hybrid of semistructured diagnostic and pretesting interviews were used to refine the content of the eyeGuide. Purposeful sampling was used to recruit a study population representative of the glaucoma patient population. Interviews were conducted until thematic saturation was reached. Interviews were audiorecorded and transcribed verbatim. Three researchers analyzed the transcripts, generated a codebook, and identified key themes using NVivo 10.0 to further refine the eyeGuide. RESULTS: Twenty-one glaucoma patients were interviewed; mean age 72±12.4 years, 5 (24%) African Americans, 9 (43%) with poor self-reported adherence, 10 (47.6%) age 75 years and above, 10 (47.6%) with poor vision, and 9 (42.9%) women. Qualitative analysis identified 5 important themes for improving glaucoma self-management: social support, patient-provider relationship, medication routine, patients' beliefs about disease and treatment, and eye drop instillation. All participants expressed satisfaction with in-person delivery of the eyeGuide and preferred this to a Web-based module. Participant feedback resulted in revised content. CONCLUSIONS: User-centered design generated improvements in the eyeGuide that would not have been possible without patient input. Participants expressed satisfaction with the tailored content.

Full Text

Duke Authors

Cited Authors

  • Killeen, OJ; MacKenzie, C; Heisler, M; Resnicow, K; Lee, PP; Newman-Casey, PA

Published Date

  • October 2016

Published In

Volume / Issue

  • 25 / 10

Start / End Page

  • 815 - 821

PubMed ID

  • 27096721

Pubmed Central ID

  • 27096721

Electronic International Standard Serial Number (EISSN)

  • 1536-481X

Digital Object Identifier (DOI)

  • 10.1097/IJG.0000000000000431


  • eng

Conference Location

  • United States